Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinoma (CROSBI ID 557966)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Glavaš-Obrovac, Ljubica ; Vladika, Ivan ; Štefanić, Mario ; Suver, Mirjana ; Mihaljević, Ivan Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinoma // European journal of nuclear medicine and molecular imaging / Carrio, I (ur.). 2009. str. S472-S-472

Podaci o odgovornosti

Glavaš-Obrovac, Ljubica ; Vladika, Ivan ; Štefanić, Mario ; Suver, Mirjana ; Mihaljević, Ivan

engleski

Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinoma

Aim was to determine clinical implications of activin A (ActA), inhibin A (InhA), and their receptors ActRI and ActRIIB mRNA expression profile testing in papillary (PTC) and follicular (FTC) thyroid carcinoma. Tissue samples were divided in 6 groups: 27 PTC, 21 FTC, 11 Hürthle cell carcinomas (HC), 16 follicular adenomas (FA), 15 Hürthle cell adenomas (HA) and 26 euthyroid multinodular goiters (MNG). RNA was isolated from 10-μm paraffin tissue sections. Gene expression was studied using reverse transcription-polymerase chain reaction (RT-PCR). An internal control gene was HPRT1. ImageQuantTL program was used for relative quantification of RT-PCR bands. Data, expressed as medians (interquartile ranges), were processed using Kruskall-Wallis test with Schaich-Hamerle post-hoc analysis. InhA, ActA and ActRI, but not ActRIIB mRNA, were expressed in the majority of tissue samples. InhA mRNA was over-expressed in HA relative to FA (P=0.00044), FTC (P=10-3) and PTC (P=2.9x10-5). HC were indistinguishable from HA, as well as FTC from FA. In contrast, InhA mRNA was consistently overexpressed in Hürthle cell neoplasms when compared to follicular variants [181 (142-205) vs 89 (70-112), HA vs FA, P=5.5x10-5 and 164 (115-176) vs 98 (81-107), % HPRT1 mRNA, HC vs FTC, P=7.9x10-5]. Moreover, InhA mRNA was over-expressed in metastatic PTC (n=10) relative to non-metastatic forms [99 (92-117) vs 84 (76-88), % HPRT1 mRNA, pN1+ vs pN0, P=0.007] ; no other differences were observed between PTC, FTC and MNG. Additionally, ActRI mRNA expression was down-regulated in FA, FTC and PTC relative to MNG (P=1.8x10-5, 6.8x10-4 and 3.3x10-4), whereas ActA mRNA was under-expressed in PTC relative to FA and, marginally, HC (P=2.3x10-3 and 8.6x10-3). Neither pT stage, nor age were related to mRNA expression in cancerous tissue specimens. Activin system is involved in the maintenance of homeostasis in normal and transformed thyrocytes: InhA, ActA and the activin signaling pathway are differentially affected by cell transformation over a broad spectrum of neoplastic phenotypes and may play role in thyroid tumorigenesis. Here, we implicate InhA mRNA expression as a possible marker of PTC aggressiveness, metastatic potential and progression.

thyroid neoplasms; inhibins; activins; gene expression

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

S472-S-472.

2009.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

European journal of nuclear medicine and molecular imaging

Carrio, I

Secaucus (NJ): Springer

1619-7070

Podaci o skupu

Annual Congress of the European Association of Nuclear Medicine (22 ; 2009)

poster

10.10.2009-14.10.2009

Barcelona, Španjolska

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost